These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 11916284)

  • 1. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
    Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
    Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study on thyroid function in patients with thalassemia major.
    Filosa A; Di Maio S; Aloj G; Acampora C
    J Pediatr Endocrinol Metab; 2006 Dec; 19(12):1397-404. PubMed ID: 17252692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exaggerated TSH response to TRH ("sub-biochemical" hypothyroidism) in prepubertal and adolescent thalassaemic patients with iron overload: prevalence and 20-year natural history.
    De Sanctis V; Tanas R; Gamberini MR; Sprocati M; Govoni MR; Marsella M
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():170-3. PubMed ID: 19337173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.
    De Sanctis V; De Sanctis E; Ricchieri P; Gubellini E; Gilli G; Gamberini MR
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():174-80. PubMed ID: 19337174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major.
    Landau H; Matoth I; Landau-Cordova Z; Goldfarb A; Rachmilewitz EA; Glaser B
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):55-61. PubMed ID: 8435886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased sensitivity to the inhibitory effect of excess iodide on thyroid function in patients with beta-thalassemia major and iron overload and the subsequent development of hypothyroidism.
    Alexandrides T; Georgopoulos N; Yarmenitis S; Vagenakis AG
    Eur J Endocrinol; 2000 Sep; 143(3):319-25. PubMed ID: 11022172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of pre-eclampsia].
    Zhou J; Du J; Ma B; Liu X; Qiu H; Li J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Feb; 49(2):109-13. PubMed ID: 24739642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
    Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency anaemia in childhood and thyroid function.
    Tienboon P; Unachak K
    Asia Pac J Clin Nutr; 2003; 12(2):198-202. PubMed ID: 12810411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.
    Cannavò S; Curtò L; Venturino M; Squadrito S; Almoto B; Narbone MC; Rao R; Trimarchi F
    J Endocrinol Invest; 2002 Mar; 25(3):236-9. PubMed ID: 11936465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid dysfunction in adult long-term survivors after hemapoeitic stem-cell transplantation (HSCT).
    Somali M; Mpatakoias V; Avramides A; Sakellari I; Smias Ch; Anagnostopoulos A; Papachristou A; Antoniadou A
    Horm Metab Res; 2005 Aug; 37(8):494-9. PubMed ID: 16138262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Function in Egyptian Children with Sickle Cell Anemia in Correlation with Iron Load.
    Hagag AA; El-Asy HM; Badraia IM; Hablas NM; El-Latif AEA
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):46-52. PubMed ID: 30207251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between thyroid hormones and renal function in severe pre-eclampsia patients with hypothyroidism].
    Zhou J; Li W; Du J; Qiao C; Shang T; Liu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Nov; 49(11):811-5. PubMed ID: 25603904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of thyroid functions and its role in body growth in thalassemia major.
    Jain M; Sinha RS; Chellani H; Anand NK
    Indian Pediatr; 1995 Feb; 32(2):213-9. PubMed ID: 8635784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in thyroid function after bone marrow transplant in young patients.
    Matsumoto M; Ishiguro H; Tomita Y; Inoue H; Yasuda Y; Shimizu T; Shinagawa T; Hattori K; Yabe H; Kubota C; Yabe M; Kato S; Shinohara O
    Pediatr Int; 2004 Jun; 46(3):291-5. PubMed ID: 15151545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
    Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
    J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.
    Russo M; Scollo C; Pellegriti G; Cotta OR; Squatrito S; Frasca F; Cannavò S; Gullo D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):614-9. PubMed ID: 26221968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.